Skip to main content
Federal Lobbying Data · Senate LDA Filings · Updated Quarterly
LobbySpend

Jazz Pharmaceuticals

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
56/100
Moderate Influence
$3.4M
Total Lobby Spend
3
Policy Issues
2
Lobbyists
1
Revolving Door

Jazz Pharmaceuticals reported $3.4 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 3 policy areas, with primary focus on Health Issues, Pharmacy, Government Issues. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

U.S. Senate
Federal Communications Commission
Securities & Exchange Commission
Dept of the Interior
National Science Foundation
Dept of Health & Human Services

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecSquire Patton Boggs
GOVPHAHCR
2$155K
2024 Jul-SepVan Scoyoc Associates
PHAHCR
1$153K
2024 Apr-JunStewart & Stewart
PHAGOVHCR
1$174K
2024 Jan-MarMehlman Consulting
HCRGOV
1$128K
2023 Oct-DecS-3 Group
HCRPHAGOV
2$165K
2023 Jul-SepHogan Lovells
PHAGOV
1$168K
2023 Apr-JunHogan Lovells
HCRGOVPHA
2$186K
2023 Jan-MarArnold & Porter
PHAGOVHCR
1$212K

Jazz Pharmaceuticals Lobbying FAQ

Jazz Pharmaceuticals has spent $3.4M on federal lobbying across 3 policy areas. This includes spending on registered lobbyists and direct government contacts.

Jazz Pharmaceuticals lobbies on 3 policy issues, including Health Issues, Pharmacy, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Jazz Pharmaceuticals has an Influence Score of 56/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Jazz Pharmaceuticals employs 2 registered lobbyists, of whom 1 have revolving door connections, meaning they previously held government positions before becoming lobbyists.

Jazz Pharmaceuticals has contacted 6 government entities as part of their lobbying activities, including U.S. Senate, Federal Communications Commission, Securities & Exchange Commission.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.